326
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Doubling of Water Intake Increases Daytime Blood Pressure and Reduces Vertigo in Healthy Subjects

, , , &
Pages 439-443 | Received 15 Sep 2009, Accepted 11 Nov 2009, Published online: 23 Sep 2010

REFERENCES

  • Melander O. Genetic factors in hypertension—what is known and what does it mean? Blood Press 2001;10:254–270.
  • New MI, Geller DS, Fallo F, Wilson RC. Monogenic low renin hypertension. Trends Endocrinol Metab 2005;16:92–97.
  • Nystrom FH, Quon MJ. Insulin signalling: metabolic pathways and mechanisms for specificity. Cell Signal 1999;11:563–574.
  • Arner P. Regional adipocity in man. J Endocrinol 1997; 155:191–192.
  • von Wowern F, Berglund G, Carlson J, Mansson H, Hedblad B, Melander O. Genetic variance of SGK-1 is associated with blood pressure, blood pressure change over time and strength of the insulin-diastolic blood pressure relationship. Kidney Int 2005;68:2164–2172.
  • Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988;297:319–328.
  • Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV, Williams B, Ford GA. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens 2006;24:215–233.
  • 2007 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2007;25:1105–1187.
  • Stookey JD, Pieper CF, Cohen HJ. Is the prevalence of dehydration among community-dwelling older adults really low? Informing current debate over the fluid recommendation for adults aged 70+years. Public Health Nutr 2005;8:1275–1285.
  • Charkoudian N, Halliwill JR, Morgan BJ, Eisenach JH, Joyner MJ. Influences of hydration on post-exercise cardiovascular control in humans. J Physiol 2003;552:635–644.
  • Nystrom F, Malmstrom O, Karlberg BE, Ohman KP. Twenty-four hour ambulatory blood pressure in the population. J Intern Med 1996;240:279–284.
  • Nystrom F, Karlberg BE, Ohman KP. Serum angiotensin-converting enzyme activity correlates positively with plasma angiotensin II: a population-based study of ambulatory blood pressure and the renin-angiotensin system. J Hum Hypertens 1997;11:301–306.
  • Brenner BM, Anderson S. The interrelationships among filtration surface area, blood pressure, and chronic renal disease. J Cardiovasc Pharmacol 1992;19(suppl 6):S1–7.
  • De Nicola L, Minutolo R, Bellizzi V, Zoccali C, Cianciaruso B, Andreucci VE, Fuiano G, Conte G. Achievement of target blood pressure levels in chronic kidney disease: a salty question? Am J Kidney Dis 2004;43:782–795.
  • Calhoun DA. Resistant or difficult-to-treat hypertension. J Clin Hypertens (Greenwich) 2006;8:181–186.
  • Jordan J. Effect of water drinking on sympathetic nervous activity and blood pressure. Curr Hypertens Rep 2005;7:17–20.
  • Lu CC, Diedrich A, Tung CS, Paranjape SY, Harris PA, Byrne DW, Jordan J, Robertson D. Water ingestion as prophylaxis against syncope. Circulation 2003;108:2660–2665.
  • Schroeder C, Bush VE, Norcliffe LJ, Luft FC, Tank J, Jordan J, Hainsworth R. Water drinking acutely improves orthostatic tolerance in healthy subjects. Circulation 2002; 106:2806–2811.
  • Shannon JR, Diedrich A, Biaggioni I, Tank J, Robertson RM, Robertson D, Jordan J. Water drinking as a treatment for orthostatic syndromes. Am J Med 2002;112:355–360.
  • Jordan J, Shannon JR, Grogan E, Biaggioni I, Robertson D. A potent pressor response elicited by drinking water. Lancet 1999;353:723.
  • Thibonnier M, Kilani A, Rahman M, DiBlasi TP, Warner K, Smith MC, Leenhardt AF, Brouard R. Effects of the nonpeptide V(1) vasopressin receptor antagonist SR49059 in hypertensive patients. Hypertension 1999;34:1293–1300.
  • Gunnet JW, Wines P, Xiang M, Rybczynski P, Andrade-Gordon P, de Garavilla L, Parry TJ, Cheung WM, Minor L, Demarest KT, Maryanoff BE, Damiano BP. Pharmacological characterization of RWJ-676070, a dual vasopressin V(1A)/V(2) receptor antagonist. Eur J Pharmacol 2008; 590:333–342.
  • Wilding JP, Norwood P, T'Joen C, Bastien A, List JF, Fiedorek FT. A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: applicability of a novel insulin-independent treatment. Diabetes Care 2009; 32:1656–1662.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.